Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 28, 2026
Why Is Bloom Energy Corporation (BE) Stock Down -9.21% Today?

Why Is Bloom Energy Corporation (BE) Stock Down -9.21% Today?

Key Takeaways

  • Bloom Energy Corporation (BE) fell 9.21% to $262.12, down $26.58 from the prior session's close of $288.70.
  • The primary catalyst was renewed fallout from Oracle's force majeure notice tied to Project Jupiter, a massive New Mexico AI data center designed to run on Bloom's fuel cells.
  • Secondary pressures included deteriorating financing conditions around the project, a securities class action deadline, and heavy profit-taking after a blockbuster run-up.
  • The decline was largely Bloom-specific: peers Generac and Cummins slipped only about 1%–2%, while broad indices fell roughly half a percent.
  • Traders are now watching execution on data-center deployments, upcoming third-quarter earnings, and any further clarity from Oracle on Project Jupiter.

Opening Summary

Bloom Energy Corporation (BE), the San Jose, California-based maker of solid-oxide fuel cell systems that generate electricity on-site for data centers and industrial facilities, saw its shares tumble sharply in Monday's session. The stock dropped 9.21%, or $26.58, to close the latest trading at $262.12, down from the prior session's closing level of $288.70. Markets attributed the move primarily to renewed uncertainty surrounding a key data-center power project linked to Oracle, compounded by profit-taking after one of the year's most explosive rallies in the clean-power and AI-infrastructure space.

Oracle's Force Majeure Notice on Project Jupiter

The dominant catalyst behind the selloff was a report that ORCL invoked a force majeure clause tied to Project Jupiter, its sprawling AI data-center campus in New Mexico designed to be powered by Bloom's gas-fueled solid-oxide fuel cells. The notice is aimed at shielding Oracle from certain financial obligations if the facility fails to come online on its targeted 2028 schedule. At the heart of the delay is a natural-gas pipeline intended to supply the site, whose completion has been pushed back by roughly six months to February 2027 following permitting setbacks.

For BE, the concern is direct: without the pipeline delivering fuel, the company's Energy Servers cannot be deployed on the original timeline, potentially shifting the timing of both shipments and associated revenue recognition. Oracle has said the project remains on schedule and that it remains committed to the development, while financier Blue Owl Capital indicated the notice does not alter its multi-year commitments. Still, investors reacted to the headline execution risk rather than the reassurances.

Funding Stress and a Looming Legal Deadline

Beyond the pipeline delay, the move reflected broader anxiety about the financing and governance surrounding Bloom's flagship growth story. Reports indicated that loans tied to the New Mexico facility have been trading at a significant discount to face value, a signal that institutional lenders are pricing in elevated execution and funding risk for the project. That stress, concentrated around Bloom's highest-profile customer relationship, reignited investor concerns about revenue concentration in a single large deployment.

Adding to the overhang, Monday marked the lead-plaintiff filing deadline in a pending securities class action against BE. The suit alleges the company made misleading disclosures about its reliance on China-sourced scandium oxide in its fuel-cell manufacturing process. Bloom has previously called short-seller allegations on the same topic "false and misleading," but the legal uncertainty has weighed on sentiment for weeks.

Market Context and Trading Activity

The decline was amplified by profit-taking following an extraordinary rally. BE entered the session up roughly 190% year to date and more than 280% over the trailing 52 weeks, leaving the stock highly vulnerable to negative headlines after such a steep climb. Notably, the move was largely company-specific rather than sector-wide: on-site power peers GNRC and CMI each slipped only about 1%–2%, confirming that the selling was concentrated in Bloom rather than a broad breakdown in the power-equipment theme.

The broader market offered little support. U.S. equities traded modestly lower, with the S&P 500 down about 0.4% and the Nasdaq off roughly 0.5%, as renewed geopolitical concerns pushed Treasury yields higher and dampened risk appetite across growth-oriented sectors. Against that backdrop, a high-beta, richly valued AI-infrastructure name like BE was an easy target for position-trimming.

What Comes Next for BE

Investors will now focus on whether the Project Jupiter uncertainty meaningfully alters Bloom's broader growth trajectory. Management has stressed that its pipeline spans multiple customers and projects at various stages of development, and that its modular servers can be redeployed between sites relatively quickly. The company's full-year 2026 guidance, which calls for revenue in the range of $3.9 billion to $4.2 billion, remains the key benchmark against which any deployment delays will be measured.

The next major catalyst is the company's third-quarter earnings report, expected in late October. Analysts will be watching for updates on order book conversion, manufacturing capacity expansion, and any revised commentary on data-center deployment timelines. Risks include further permitting or financing setbacks on large projects, ongoing litigation, and the stock's elevated valuation, which leaves limited room for error against high growth expectations.

Trending AI Robots

Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving traders a way to monitor momentum across a shifting market landscape. Explore the Trending AI Robots page to see which automated strategies are currently leading the field.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BE

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


BE in upward trend: 10-day moving average moved above 50-day moving average on September 09, 2026

The 10-day moving average for BE crossed bullishly above the 50-day moving average on September 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on BE as a result. In 61 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

BE moved above its 50-day moving average on September 03, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where BE advanced for three days, in 266 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 242 of 262 cases where BE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for BE moved out of overbought territory on September 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 35 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 59 cases where BE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for BE turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 33 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

BE broke above its upper Bollinger Band on September 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 33 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. BE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BE's P/B Ratio (48.077) is very high in comparison to the industry average of (7.529). BE's P/E Ratio (341.390) is considerably higher than the industry average of (54.807). Projected Growth (PEG Ratio) (0.594) is also within normal values, averaging (2.900). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (24.876) is also within normal values, averaging (8.080).

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Plug Power (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL), GrafTech International Ltd (NYSE:EAF).

Industry description

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

Market Cap

The average market capitalization across the Electrical Products Industry is 5.46B. The market cap for tickers in the group ranges from 750 to 205.24B. CYATY holds the highest valuation in this group at 205.24B. The lowest valued company is EDYYF at 750.

High and low price notable news

The average weekly price growth across all stocks in the Electrical Products Industry was -0%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -8%. NEOV experienced the highest price growth at 30%, while EPOW experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Electrical Products Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 74
Price Growth Rating: 63
SMR Rating: 84
Profit Risk Rating: 85
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
BE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of on-site electric power solutions

Industry ElectricalProducts

Industry
Electrical Products
Address
4353 North First Street
Phone
+1 408 543-1500
Employees
2214
Web
https://www.bloomenergy.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.